The market has been down on Precision BioSciences Inc (DTIL) stock recently. DTIL gets a Bearish score from InvestorsObserver Stock Sentiment Indicator.
Precision BioSciences Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on DTIL!
When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment.
Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish.
InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion.
For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.
What's Happening With DTIL Stock Today?
Precision BioSciences Inc (DTIL) stock is lower by -1.67% while the S&P 500 is higher by 0.28% as of 11:00 AM on Wednesday, Dec 7. DTIL has fallen -$0.02 from the previous closing price of $1.20 on volume of 253,310 shares. Over the past year the S&P 500 is lower by -13.93% while DTIL has fallen -85.71%. DTIL lost -$1.50 per share in the over the last 12 months.
To screen for more stocks like Precision BioSciences Inc click here.
More About Precision BioSciences Inc
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The company's segments include Therapeutics and Food out of which the Therapeutics segment act as a key revenue driver for the firm.
Click Here to get the full Stock Report for Precision BioSciences Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
